4th Quarter - Report

THE MCMANUS GROUP for GENENTECH

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA approval and enforcement issues. 340B payment and implementation issues.

Foreign entity interest: 100% ownership by Roche Holding Ltd., 4070 Basel, Switzerland.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare coverage and payment of Part B drugs and biologicals. Support for H.R. 452 "Medicare Decisions Accountability Act of 2011" and S. 668 "Health Care Bureaucrats Elimination Act." 340B payment and implementation issues.

Foreign entity interest: 100% ownership by Roche Holding Ltd., 4070 Basel, Switzerland.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
NICK SHIPLEY Legislative Director, Rep. Jay Inslee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 452 (112th), S. 668 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.